Delivery Order SPE2DB20D3101-SPE2DB25FRDQ6

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,454.50 firm fixed-price contract is for the delivery of 4,564,677,032 Telmisartan 20 mg tablets in 30-count packages. The contract has an ultimate completion date of May 22, 2024. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024. The contract, valued at $1,948.20, is for the delivery of Telmisartan 20 mg tablets. The contract has a period of performance through December 6, 2024 and is a Firm Fixed Price type. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,033.26, is for the delivery of telmisartan 20 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and has an Ultimate Completion Date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,118,329 units of Telmisartan 20 mg tablet, a cardiovascular medication, with a ceiling value of $1,316.34. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,539.06, is a Delivery Order for the provision of Telmisartan 20 mg Tablets 30s, a cardiovascular medication. The contract has an ultimate completion date of December 27, 2024 and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of Telmisartan 20 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a ceiling value of $1,258.13. It does not have a set-aside designation. Amerisourcebergen Drug Corporation is the prime contractor,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract has a firm-fixed price of $1,355.12 and an ultimate completion date of August 21, 2024. AmerisourceBergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,123.07, is for the delivery of telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has a completion date of February 19, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,423.51 firm fixed-price delivery order is for the supply of 4,563,062 units of Telmisartan 20 mg tablets. The contract has an ultimate completion date of December 12, 2023 and was awarded on December 11, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan 40 mg tablets, with a ceiling value of $1,424.67 and a period of performance through March 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRDQ6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.87, is for the delivery of Telmisartan 20 mg tablets in 30-count packages. The contract has a period of performance through March 5, 2025 and utilizes a firm-fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/3/25, 9:49 AM